Long-term registry of people with severe asthma in Italy
Collects real-life data on people with severe asthma over time, including biologic treatments.
Plain-language title generated from the registry record
Registry title: Severe Asthma Network Italy
Key facts
- Where
- Rozzano, ItalySee the site
Where in Italy
- Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital, Rozzano, ItalyRozzano, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Società Italiana di Allergologia, Asma e Immunologia Clinica
- Trial code
- NCT06625216
- Record updated
- 29 April 2026
- Original description
The goal of this registry is collecting data of severe asthma patients, recruited by specialized centers, in a real life setting, homogeneously placed on a database management system to follow them over the time.Read full original descriptionShow less
Observatory of Patients With Severe Asthma and Potential Eligible Patients for Treatment With Biological Drugs
The goal of this registry is collecting data of severe asthma patients, recruited by specialized centers, in a real life setting, homogeneously placed on a database management system to follow them over the time.
The information recorded will provide:
1. The collection of homogeneous clinical, functional and biologic data of patients with severe asthma in a real life setting. 2. The evaluation of adherence to treatment in real life. 3. The clinical eligibility of patients treated with biologics. 4. The evaluation of patients' clinical response to each treatment. 5. The monitoring of tolerability and safety. 6. The long-term follow up of patients with severe asthma.
Inclusion: signed informed consent and privacy disclaimer; age > 12 years; diagnosis of severe asthma according to the ERS/ATS criteria:; During treatment with:; High-dose ICS + at least one addistional controller (LABA, montelukast, or theophylline) or; Oral corticosteroids >6 months/year; at least one of the following occurs or would occur if treatment would be reduced:; ACT <20 or ACQ>1.5; At least 2 exacerbations in the last 12 months; At least 1 exacerbation treated in hospital or requiring mechanical ventilation in the last 12 months; FEV1 <80% (if FEV1/FVC below the lower limit of normal).